Schedules of Controlled Substances: Proposed Placement of Sibutramine Into Schedule IV

This proposed rule is issued by the Acting Deputy Administrator of the DEA to place the substance, sibutramine, including its salts and optical isomers into Schedule IV of the Controlled Substances Act (CSA). This proposed action is based on a recommendation from the Assistant Secretary for Health of the Department of Health and Human Services (DHHS) that sibutramine be added to Schedule IV and on an evaluation of the relevant data by the DEA. If finalized, this action will impose the regulatory controls and criminal sanctions of Schedule IV on those who handle sibutramine and products containing sibutramine.